ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 72 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $28,000 | -53.3% | 45,135 | -1.6% | 0.00% | – |
| Q3 2018 | $60,000 | -3.2% | 45,851 | -0.0% | 0.00% | – |
| Q2 2018 | $62,000 | -85.7% | 45,857 | -84.7% | 0.00% | – |
| Q1 2018 | $435,000 | -34.2% | 299,830 | +2.0% | 0.00% | – |
| Q4 2017 | $661,000 | -33.4% | 294,005 | +0.6% | 0.00% | – |
| Q3 2017 | $993,000 | -6.1% | 292,151 | -2.0% | 0.00% | – |
| Q2 2017 | $1,058,000 | +29.7% | 298,054 | +24.2% | 0.00% | – |
| Q1 2017 | $816,000 | -27.3% | 239,920 | -1.7% | 0.00% | – |
| Q4 2016 | $1,123,000 | +8.8% | 244,175 | +0.4% | 0.00% | – |
| Q3 2016 | $1,032,000 | +209.0% | 243,261 | +74.8% | 0.00% | – |
| Q2 2016 | $334,000 | -37.8% | 139,175 | +21.7% | 0.00% | – |
| Q1 2016 | $537,000 | +17.8% | 114,331 | -1.4% | 0.00% | – |
| Q4 2015 | $456,000 | +1.1% | 116,013 | -0.4% | 0.00% | – |
| Q3 2015 | $451,000 | +526.4% | 116,509 | +651.8% | 0.00% | – |
| Q2 2015 | $72,000 | – | 15,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 5,292,156 | $7,674,000 | 1.12% |
| Northeast Financial Consultants Inc | 732,265 | $1,061,000 | 0.36% |
| Family Management Corp | 10,424 | $15,000 | 0.01% |
| AJ WEALTH STRATEGIES, LLC | 15,000 | $22,000 | 0.01% |
| Poehling Capital Management, INC. | 3,302 | $5,000 | 0.00% |
| A.R.T. Advisors, LLC | 48,692 | $70,000 | 0.00% |
| Virtu Financial LLC | 34,383 | $50,000 | 0.00% |
| Founders Capital Management | 3,000 | $4,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 151,854 | $220,000 | 0.00% |
| BEACON INVESTMENT ADVISORY SERVICES, INC. | 10,500 | $15,000 | 0.00% |